nasdaq edit stock forecast

According to the issued ratings of 11 analysts in the last year the consensus rating for Editas Medicine stock is Hold based on the current 2 sell ratings 4 hold ratings and 5. Nasdaq edit stock forecast Monday March 21 2022 Sign up for the latest on how to invest in Nasdaq-100 Index Options.

Edit Stock Price And Chart Nasdaq Edit Tradingview

In early trading on Thursday shares of Intel topped the list of the days best performing components of the Nasdaq 100 index trading up 29.

. With a 5-year investment the revenue is expected to be around. Common Stock EDIT Stock Quotes - Nasdaq offers stock quotes market activity data for US and global markets. EDIT Editas Medicines current Earnings Per Share EPS is -285.

New target price is 120 above last closing price of US1690. On average analysts forecast that EDITs EPS will be -324 for 2022 with the lowest EPS forecast at. Stock Price Forecast The 13 analysts offering 12-month price forecasts for Editas Medicine Inc have a median target of 2700 with a high estimate of 8000 and a low estimate of 1000.

Stock is down 61 over the past. Year to date Intel has lost. Editas Medicine stock price prediction is an act of determining the future value of Editas Medicine shares using few different conventional methods such as EPS.

Since breakout we go small rejection at 73 however this. This is what breakout trading is about. USD 1613 116 671.

Since breakout we go small rejection at 73 however this is the biggest moment. The forecast for beginning of March 15559. ET View Interactive EDIT Charts.

Earnings for Editas Medicine are expected to grow in the coming year from 324 to 320 per share. Maximum value 17083 while minimum 15149. 1 day agoThe Dow spiked 25447 points or 074 percent to finish at 3480746 while the NASDAQ surged 27036 points or 195 percent to end at 1410882 and the SP 500 climbed.

Price as of March 18 2022 400 pm. Find the latest Editas Medicine Inc. Based on our forecasts a long-term increase is expected the EDIT stock price prognosis for 2027-02-17 is 42518 USD.

26 rows NASDAQ predictions for March 2023. Editas Medicine has not formally confirmed its next earnings publication. Editas Medicine is a pioneer in gene editing technology.

You wait for a confirmed backtest. Down from US4514 the current price target is an average from 11 analysts. EDIT stock quote history news and other vital information to help you with your stock trading and investing.

Averaged NASDAQ value for.

My 3 Biggest Stock Market Predictions For January Nasdaq